BIOTECH
The technical information, process specifications and product content on this page are intended solely for internal academic exchange and technical reference by qualified medical professionals. HERBEST does not use this page to advertise, promote or sell medical services to the general public.
Precision in preparation.
PLTex originates from the standardised PLT2.0 preparation platform at HERBEST Biotech’s laboratory. The process includes blood-component separation, concentration, selected-component filtration and lyophilised preparation, with contract preparation and quality management carried out under established procedures.
The Chinese name echoes “Better”, reflecting the ongoing refinement of process specifications and quality-control procedures. Actual specifications, test methods and acceptance criteria are governed by the test results and contract documentation for each batch.
Standardised processes and quality management · BioCraft Lab × PLTex
Original laboratory introduction video in Chinese.
Comparison
PRP
PLT2.0
PLTex
Technology & composition
Platelet-rich plasma
Highly concentrated lyophilised preparation
Multi-component lyophilised preparation
Specifications & quantitative indicators
Depend on the preparation system and testing procedures used by each institution.
Refer to the test results and contract documentation for each batch.
Component specifications and quantitative indicators are governed by batch test results and contract documentation.
Preparation process / time
In-clinic centrifugation; approximately 20 minutes.
Separation and freeze-drying in a sterile laboratory; 14 working days.
Separation and freeze-drying in a sterile laboratory; 14 working days.
Storage conditions & shelf life
Depend on the preparation system and operating procedures.
Please refer to the applicable batch documentation.
Governed by stability data and the documentation for each batch.
Safety & sterilisation processing
Depend on the system and operating procedures used by each institution.
Processing conditions follow established quality-management procedures and batch documentation.
Please refer to the applicable batch documentation.
Leukocyte / mononuclear-cell filtration
Centrifugation only
Centrifugation with leukocyte / mononuclear-cell filtration
Centrifugation with leukocyte / mononuclear-cell filtration
Research platform characteristics
Basic preparation for immediate, single-session use
Standardised lyophilised preparation with batch quality management
Multi-component preparation with batch specification management
Preparation & allocation options
Prepared according to the selected system and contract specifications.
Single-batch preparation and aliquot planning according to contract specifications.
Single-batch preparation, aliquoting and quality-document management according to the commissioned requirements.
This platform provides only standardised laboratory preparation and contract quality-control services (CRDMO) for autologous blood components. Research data and specifications are provided for academic discussion only. This page does not provide advice on diagnosis, treatment or human use.
General reference range: approximately 150–400 × 10⁹/L. The reference standards of the testing institution take precedence.
Examples of test parameters
PDGF · Platelet-derived growth factor
VEGF · Vascular endothelial growth factor
KGF · Keratinocyte growth factor
TGF-α / TGF-β · Transforming growth factors
EGF · Epidermal growth factor
FGF · Fibroblast growth factor
Actual test parameters and results are governed by the report for each batch.
EXPLORE THE COLLECTION
BIOTECH
Where expertise and aesthetics meet.
This website is intended for medical and biotechnology professionals. Members of the public should consult a qualified healthcare provider.
© 2026 HERBEST BIOTECH